Accuray - ARAY Operating profit EBITDA
Is it worth investing in Accuray Incorporated (ARAY), which seeks to capture the precision radiation niche through AI implementation and expansion into new markets? The time trajectory on the GURU.Markets chart for aggregated EBITDA provides the answer, where the value 11.27 represents the latest figure. Energy-efficient production and ESG supply chain audits, alongside maximum capacity utilization of robotic system plants without downtime, bolster the business's resilience.
Accuray (ARAY) - metric breakdowns and financial figures
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital Accuray Incorporated|ARAY - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Accuray Inc|ARAY - Company Aggregate Debts|Debt to Book Value Accuray Incorporated|ARAY - Company Long-Term Liabilities|Company Short-Term Debts Accuray Incorporated|Intermediate Coverage Ratio accuray.com
- earnings and market ratios statistics:
ARAY - Net Profit|Projected Future Earnings Accuray Incorporated|ARAY - Price to Earnings Ratio|Projected Price to Earnings Ratio accuray.com|ARAY - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Accuray Incorporated|ARAY - Operating profit EBITDA|Net earnings per share for the last four quarters Accuray Incorporated|ARAY - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months accuray.com|ARAY - Earnings growth in current year|Expected earnings per share growth for next year Accuray Incorporated
Summary company analytics:ARAY - Accuray, Inc.
Analyzing the absolute EBITDA trend allows for an assessment of Accuray Incorporated (ARAY) within the radiosurgery sector through the lens of its ability to monetize the integration of AI into CyberKnife systems. This indicator captures the actual cash flow from core operations without depreciation distortions, where profit growth confirms the effectiveness of strategic alliances with radiology centers and the overall resilience of the business model.
Competitor analysis for Accuray Incorporated
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit EBITDA PSNL|Operating profit EBITDA erasca.com (ERAS)|Operating profit EBITDA DCTH (Delcath Systems)|YMAB - Operating profit before deduction of amortization|Aura Bio - Operating profit EBITDA|Candel Therapeutics (CADL) - Operating profit before deduction of amortization|SLS (sellaslifesciences.com) - Operating profit before deduction of amortization|actuatetherapeutics.com (ACTU) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Citius Oncology|HURA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA TARA|Operating profit EBITDA Fate Pharma (FATE)|Aadi Bioscience - Operating profit before deduction of amortization|TScan Therapeutics Inc (TCRX) - Profit before interest, taxes and amortization|CSBR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization XBIT (XBiotech Inc.)|CVM: Operating profit EBITDA|OSTX - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Radiopharm Theranostics|Operating profit before amortization ARTV (Artiva)|Operating profit EBITDA ANL|Operating profit before deduction of amortization Veru Inc VERU|Profit before payment of interest, taxes and amortization Tempest Tx TPST|Xilio Therapeutics Inc (XLO) - Profit before interest, taxes and amortization|RENB - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization MURA (Mural Oncology plc)|kairospharma.com (KAPA) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization OKUR (OnKure Therapeutics)|Profit before payment of interest, taxes and amortization CytoMed Therapeutics Ltd|Profit before interest, taxes and amortization Curis Corp CRIS|Profit before payment of interest, taxes and amortization Apollomics, Inc. (APLM)|THAR (tharimmune.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ADVB (Advanced Biomed)|Operating profit EBITDA Genprex Inc. GNPX|CLDI: Operating profit before deduction of amortization|sunshinebiopharma.com - Company profit before taxes, interest and amortization|XBIO: Operating profit EBITDA|Profit before interest, taxes and amortization salariuspharma.com (SLRX)|PPBT (Purple Biotech Ltd.) - Operating profit EBITDA|Operating profit before amortization AONC (AON)|Operating profit EBITDA BGNE|Operating profit EBITDA Checkpoint Therapeutics Inc (CKPT)|Profit before payment of interest, taxes and amortization Elevation Oncology ELEV|Income before deduction of interest, taxes and amortization ICAD|Ikena - Operating profit EBITDA|NTBL - Operating profit EBITDA|VIRX (viracta.com) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit before deduction of amortization ascentage.com (AAPGV)
